Linda Graudins

Mrs. Linda Graudins

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in European Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
AAAr Kar Aung
Ar Kar Aung
SWSteven Walker
Steven Walker
YKYin Li Khu
Yin Li Khu
MTMei Jie Tang
Mei Jie Tang
JLJennifer I. Lee
Jennifer I. Lee
LGLinda Graudins
Linda Graudins
Purpose: Adverse drug reactions (ADRs) contribute significantly to healthcare burden. However, they are largely preventable through appropriate management processes. This narrative review aims to identify the quality indicators that should be considered for routine monitoring of processes within hospital ADR management systems. It also examines the potential reasons behind variation in ADR management practices amongst HCPs, and explores possible solutions, focusing on targeted education programmes, to improve both the quality and quantity indicators of ADR management processes. Methods: A comprehensive literature review was conducted to explore relevant themes and topics concerning ADR management, quality indicators and educational interventions. Results: Substantial variability exists in ADR management amongst healthcare professionals (HCPs) with regard to reporting rates, characteristics of ADRs reported, quality of assessment, completeness of reports and, most importantly, risk communication practices. These variable practices not only threaten patient safety but also undermine pharmacovigilance processes. To date, quality indicators to monitor ADR management practices within hospital settings remain ill-defined. Furthermore, evidence behind effective interventions, especially in the form of targeted education strategies, to improve the quality of ADR management remains limited. Conclusions: The focus of ADR management in hospitals should be to promote patient safety through comprehensive assessment, risk communication and safe prescribing. There is a need to develop a system to define, measure and monitor the quality of ADR management. Educational strategies may help improve the quality of ADR management processes.

1 March 2020 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
HSHelen E. Stark
Helen E. Stark
LGLinda Graudins
Linda Graudins
TMTreasure M. McGuire
Treasure M. McGuire
CLCathy Yuen Yi Lee
Cathy Yuen Yi Lee
MDMargaret J. Duguid
Margaret J. Duguid

8 January 2018 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
WFWendy C. Fang
Wendy C. Fang
NANikki R. Adler
Nikki R. Adler
LGLinda Graudins
Linda Graudins
CGCaitlin Goldblatt
Caitlin Goldblatt
MGMichelle S. Y. Goh
Michelle S. Y. Goh
AAAr Kar Aung
Ar Kar Aung

18 July 2016 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
LGLinda Graudins
Linda Graudins
JLJennifer Ly
Jennifer Ly
JTJason Trubiano
Jason Trubiano
AAAr Kar Aung
Ar Kar Aung

1 May 2020 in Burns
Verified
Journal Article
Closed access
HBHarmeet K. Bhullar
Harmeet K. Bhullar
AAAr Kar Aung
Ar Kar Aung
LGLinda Graudins
Linda Graudins
JIJosh Ihle
Josh Ihle
DGDouglas Gin
Douglas Gin
BTBing Mei Teh
Bing Mei Teh

27 July 2018 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
PDF file
LGLinda Graudins
Linda Graudins
JTJason A. Trubiano
Jason A. Trubiano
CZCelia M. Zubrinich
Celia M. Zubrinich
AEAinslee S. Elliott
Ainslee S. Elliott
AAAr Kar Aung
Ar Kar Aung